CANbridge Pharmaceuticals to Participate in the Morgan Stanley Virtual China Summit 2022

BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today announced that it will participate in the Morgan Stanley Virtual China Summit 2022 to be held on May 24-26, 2022. About CANbridge Pharmaceuticals Inc. CANbridge Pharmaceuticals … [Read more…]

Sonendo, Inc. to Present at the Stifel Jaws and Paws Conference

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will be participating in the upcoming Stifel Jaws and Paws Conference. Bjarne Bergheim, President & Chief Executive Officer, and Michael Watts, Chief Financial Officer, are scheduled to present on Wednesday, June 1 at … [Read more…]

Align Technology Introduces Invisalign Outcome Simulator Pro, Next Generation Patient Communication Tool Featuring In-Face Visualization of a Patient’s Potential Future Smile in Minutes

Available on iTero Element Plus series scanners and imaging systems. Advanced algorithms generate realistic simulations of Invisalign treatment outcomes, available in both in-face and 3D dentition views, to help drive patient education and treatment acceptance. TEMPE, Ariz. & MIAMI & COPENHAGEN, Denmark & LONDON–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device … [Read more…]

ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China

The signed agreement establishes beachhead to broadly market and distribute Tru Niagen® to Mainland China’s aging population LOS ANGELES–(BUSINESS WIRE)–$CDXC #NAD–ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced it has entered into an agreement (the “JV Agreement”) to establish a joint venture through its wholly owned subsidiary ChromaDex … [Read more…]

4D pharma to Present at the H.C. Wainwright Global Investment Conference

LEEDS, UK,–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced that Duncan Peyton, Chief Executive Officer of 4D pharma, will present at the H.C. Wainwright Global Investment Conference. The presentation will be available for … [Read more…]

CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock

LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series D Preferred Stock, par value $0.01 per share, for each outstanding share of … [Read more…]

WeWork and BetterHelp Partner on Mental Health Awareness Month Initiative to Provide Free Access to Therapy Nationwide

In honor of Mental Health Awareness Month, the companies are offering access to free professional therapy as well as wellness events to WeWork members around the country NEW YORK–(BUSINESS WIRE)–WeWork (NYSE: WE), a leading flexible space provider, and BetterHelp, the world’s largest therapy platform, today announced a paid partnership to provide access to a free … [Read more…]

Southeastern Grocers Donates $395,000 to Children’s Hospitals Across the Southeast

Grocer and customers show support for pediatric care facilities during National Cancer Research Month JACKSONVILLE, Fla.–(BUSINESS WIRE)–Southeastern Grocers Inc. (SEG), parent company and home of Fresco y Más, Harveys Supermarket and Winn-Dixie grocery stores, announces a donation of $395,000 to nine children’s hospitals across the Southeast. In recognition of National Cancer Research Month, SEG’s generous … [Read more…]

Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today was officially recognized as the number one philanthropic funder of HIV-related programs in a new tracking report released by Funders Concerned About AIDS (FCAA). The report, found at: https://www.fcaaids.org/inform/philanthropic-support-to-address-hiv-aids/, is released annually and is widely regarded as the most comprehensive study of its kind. It analyzes … [Read more…]